Talis Biomedical Corp (TLIS)
9.15
+0.20
(+2.23%)
USD |
NASDAQ |
May 16, 16:00
9.15
0.00 (0.00%)
After-Hours: 20:00
Talis Biomedical Gross Profit Margin (Quarterly): 91.78% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 91.78% |
| December 31, 2023 | 94.70% |
| September 30, 2023 | 92.11% |
| June 30, 2023 | 85.42% |
| March 31, 2023 | 85.40% |
| Date | Value |
|---|---|
| December 31, 2022 | -2.08K% |
| September 30, 2022 | -69.32% |
| June 30, 2022 | -159.4% |
| March 31, 2022 | -52.23% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-2.08K%
Minimum
Dec 2022
94.70%
Maximum
Dec 2023
-212.3%
Average
85.40%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 10.78% |
| Xtant Medical Holdings Inc | 60.97% |
| Asensus Surgical Inc | 21.47% |
| Catheter Precision Inc | 93.90% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -69.15% |
| Return on Assets | -52.92% |
| Return on Invested Capital | -69.15% |
| Profit Margin (Quarterly) | -17.86K% |
| Operating Margin (Quarterly) | -19.34K% |
| Return on Net Operating Assets | -368.6% |